Celldex Therapeutics Stock Analysis

Celldex Stock Analysis Notes

About 100.0% of the company shares are held by institutions such as insurance companies. The book value of Celldex Therapeutics was currently reported as 10.59. The company recorded a loss per share of 2.7. Celldex Therapeutics last dividend was issued on the 11th of February 2019. The entity had 1:15 split on the 11th of February 2019. Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Celldex Therapeutics, Inc. was incorporated in 1983 and is headquartered in Hampton, New Jersey. Celldex Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 132 people. For more info on Celldex Therapeutics please contact the company at 908 200 7500 or go to https://www.celldex.com.

Celldex Therapeutics Investment Alerts

Celldex Therapeutics Upcoming and Recent Events

Celldex Largest EPS Surprises

View All Earnings Estimates

Celldex Therapeutics Environmental, Social, and Governance (ESG) Scores

Celldex Therapeutics Thematic Classifications

Celldex Stock Institutional Investors

Note, although Celldex Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Celldex Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.49 B.

Celldex Profitablity

Management Efficiency

Celldex Therapeutics has return on total asset (ROA) of (0.1688) % which means that it has lost $0.1688 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.232) %, meaning that it created substantial loss on money invested by shareholders. Celldex Therapeutics' management efficiency ratios could be used to measure how well Celldex Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.22 in 2025. Return On Capital Employed is likely to drop to -0.27 in 2025. At this time, Celldex Therapeutics' Total Assets are fairly stable compared to the past year. Other Current Assets is likely to rise to about 22.2 M in 2025, whereas Non Current Assets Total are likely to drop slightly above 31.5 M in 2025.

Technical Drivers

As of the 19th of July, Celldex Therapeutics shows the Mean Deviation of 2.74, risk adjusted performance of 0.114, and Downside Deviation of 2.99. Celldex Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Celldex Therapeutics Price Movement Analysis

Celldex Therapeutics Insider Trading Activities

Celldex Therapeutics Outstanding Bonds

Celldex Therapeutics Predictive Daily Indicators

Celldex Therapeutics Corporate Filings

Celldex Therapeutics Forecast Models

Celldex Therapeutics' time-series forecasting models are one of many Celldex Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Celldex Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Celldex Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Celldex shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Celldex Therapeutics. By using and applying Celldex Stock analysis, traders can create a robust methodology for identifying Celldex entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Celldex analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Celldex analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Celldex Therapeutics stock analysis indicators help investors evaluate how Celldex Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Celldex Therapeutics shares will generate the highest return on investment. By understating and applying Celldex Therapeutics stock analysis, traders can identify Celldex Therapeutics position entry and exit signals to maximize returns.

When running Celldex Therapeutics' price analysis, check to measure Celldex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celldex Therapeutics is operating at the current time. Most of Celldex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Celldex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celldex Therapeutics' price. Additionally, you may evaluate how the addition of Celldex Therapeutics to your portfolios can decrease your overall portfolio volatility.